Japan GM2 Gangliosidosis Market Trends, Forecast Report 2035
GM2 gangliosidosis represents a collection of uncommon genetic disorders which result from a complete lack of beta-hexosaminidase enzymatic activity, leading to GM2 ganglioside accumulation within the central nervous system. The disorder includes Tay-Sachs disease, Sandhoff disease, and the AB variant. The disorder primarily impacts infants and children through progressive neurodegeneration and motor dysfunction and cognitive decline.